News

Apogee Therapeutics' Upcoming Investor Conference Participation

Apogee Therapeutics' Upcoming Investor Conference Participation

Engagement with Investors: March Conferences

Apogee Therapeutics, Inc. (NASDAQ: APGE), a pioneering biotechnology firm, has announced its participation in several key investor conferences this March. Based in San Francisco and Boston, the company is dedicated to advancing its innovative treatments within the inflammatory and immunological markets.

Your Chance to Connect with Management

The management team at Apogee will be present at noteworthy events, making it an excellent opportunity for investors to engage with them directly. This interaction provides insights into the company’s progress and future plans in the biotechnology sector.

Scheduled Conferences

Here are the details of the upcoming conferences:

  • TD Cowen 45th Annual Health Care Conference
    Date: March 4, 2025
    Time: 2:30 PM ET
  • Leerink Global Healthcare Conference
    Date: March 11, 2025
    Time: 8:40 AM ET

About Apogee Therapeutics

Apogee Therapeutics specializes in the development of novel biologics aimed at addressing significant medical needs in inflammatory and immunology sectors. Among their projects, they are focusing on treatments for conditions such as atopic dermatitis, asthma, chronic obstructive pulmonary disease, and eosinophilic esophagitis. Their lead program, APG777, is expected to fill a crucial gap in the market for atopic dermatitis.

Innovative Antibody Programs

What sets Apogee apart is its strategic approach to developing antibody therapies that tackle the shortcomings of current treatments. By leveraging advanced antibody engineering techniques, they aim to enhance the efficacy and duration of their therapies. This scientific edge could allow them to position their products as best-in-class alternatives.

Transforming Patient Care

Apogee's focus on monotherapies and combination treatments highlights their commitment to improving patient outcomes in the fields of immunology and inflammation. Their dedication to rigorous research and innovative development represents a beacon of hope for patients who have not found success with existing therapies.

Investor and Media Contacts

For those interested in more information or who wish to connect with the company, Apogee Therapeutics has provided their contact details:

Investor Contact:
Noel Kurdi
VP, Investor Relations
Apogee Therapeutics, Inc.
Email: noel.kurdi@apogeetherapeutics.com

Media Contact:
Dan Budwick
Email: dan@1abmedia.com

Frequently Asked Questions

What is Apogee Therapeutics?

Apogee Therapeutics is a biotechnology company focused on developing treatments for immunological and inflammatory disorders.

When are the investor conferences?

The conferences are scheduled for March 4 and March 11, 2025.

How can I attend the conferences?

Details on attending the conferences can often be found on the respective conference websites.

What therapies is Apogee developing?

Apogee is developing therapies targeted at conditions such as atopic dermatitis and asthma, utilizing advanced biologics.

How can I contact Apogee for more information?

You can reach out to investor relations at noel.kurdi@apogeetherapeutics.com for inquiries.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

DKS Lawsuit Deadline: Investors Must Act by Nov 3, 2026

Updated Category News Views 78

Clock's Ticking for DICK'S Investors If you've got money tied up in DICK'S Sporting Goods—bought between September 8, 2025, and August 24, 2026—listen up. There's a class action lawsuit aiming to recover some of what might've slipped through your fingers. Come November 3, 2026, the door slams shut on your chance to get involved. What's the Beef? Apparently, DICK'S had...

Continue Reading
Fashion and Philanthropy Unite at UBCF Kick-off Party

Updated Category News Views 65

Exclusivity and Dedication Mix at UBCF Event When fashion and philanthropy get together, you better believe it's more than just a pleasant evening. The Frederick Anderson Collection is hosting a swanky cocktail reception, kicking off the United Breast Cancer Foundation's (UBCF) highly-anticipated Think Pink Gala, and it's shaping up to be a unique affair wrapped in...

Continue Reading
Duolingo Investors Must Weigh Legal Options Now

Updated Category News Views 141

Pressure Mounts on Duolingo Amid Legal Turmoil Well, here's a riddle solved with a lawsuit: when an app's growth hits the brakes, the lawyers seem to get moving fast. It seems like Duolingo, Inc. (NasdaqGS: DUOL) is learning a harsh lesson—not exactly in Spanish or French, but in the courtroom. They've been slapped with a securities class action, and it ain't looking...

Continue Reading
Main Street Merger Faces Scrutiny: What It Means for Shareholders

Updated Category News Views 51

Under the Radar, but Not for Long Ah, mergers—those grand gestures in corporate America that promise growth, synergy, and shareholder value. But not every deal is a head-turner; some fly under the radar until someone grabs the magnifying glass. And that's exactly what's happening with Main Street Financial Services Corp.'s (OTC: MSWV) proposed merger with First...

Continue Reading
Bass Angler Matt Robertson Reels in Record $1.25M Prize

Updated Category News Views 13

A New Era for Bass Fishing Payouts Who would have thought we'd see the day when bass fishing turned out to be as lucrative as a Wall Street handshake? But here we are, with Matt Robertson hauling in a whopping $1.25 million prize at World Bass Enterprises' first "The Champions" Tournament. We're not talking chump change here—this is the real deal in a sport often...

Continue Reading
Redtail Tech Faces California Labor Code Allegations

Updated Category News Views 183

Redtail Technology Caught in Legal Crosshairs The legal arena is heating up as Redtail Technology, Inc. finds itself on the receiving end of a class action lawsuit. Filed by the attorneys at Blumenthal Nordrehaug Bhowmik De Blouw LLP, the suit hammers Redtail for allegedly failing to honor California's strict meal and rest period requirements, alongside other labor code...

Continue Reading
UBCF & GGP Join Forces for Nationwide Pink Bag Drive

Updated Category News Views 153

Caring Through Community: Pink Bag Events Unroll What do you get when compassion meets action? That's the story with the United Breast Cancer Foundation (UBCF) and GGP's Pink Bag Event. Here in 2026, these folks are doing something so damn important, you'd wonder why more don’t follow suit. For the fifth straight year, they're rolling out a campaign that bridges the gap...

Continue Reading
HK Boosts Oversight of Building Repairs Post-Blaze

Updated Category News Views 144

Big Moves After a Tragic Fire Hong Kong's revamping its approach to building maintenance and oversight, clearly in reaction to the horrific Wang Fuk Court blaze last year. That fire didn't just leave scars; it blew open glaring gaps in the city's oversight of building repairs. The government's now jumping into action by launching a raft of measures aimed at preventing...

Continue Reading
Alignment Healthcare Faces Investigation Over Alleged Fraud

Updated Category News Views 76

Rough Waters at Alignment Healthcare Not every day we hear about a company sinking its own ship over bookkeeping shenanigans, but here we are. Alignment Healthcare, sitting on Nasdaq under ticker ALHC, is facing the kind of scrutiny that sends shivers down a boardroom's spine. Yeah, Kahn Swick & Foti—those big hitters in securities litigation—have launched an...

Continue Reading
NIDS Aims Global with CES 2027, Boosts Sensor Supply

Updated Category News Views 189

Pushing Boundaries at CES 2027 Kicking into high gear, NIDS Co., Ltd. is eyeing the CES 2027 stage like it's their personal gold rush. Already a heavyweight in environmental sensors, the company is all set to seize fresh international opportunities and expand their B2B supply footprint worldwide. Already Turning Heads Founded back in 2000, NIDS ain't new to the sensor...

Continue Reading

Top 5 Most Recently Viewed Articles

Exciting Updates from PacBio for Investors This June 2025

Updated Category News Views 273

Upcoming Investor Conferences for PacBio PACBIO, renowned for its cutting-edge sequencing solutions, is gearing up to engage with investors at notable conferences scheduled for June. Primarily recognized under the ticker NASDAQ: PACB, this life science technology company has made significant strides in providing advanced sequencing capabilities. Details of Investor...

Continue Reading
Understanding TC Transcontinental's Strategic Shift in Packaging

Updated Category News Views 301

TC Transcontinental's Bold Business Move Recently, TC Transcontinental, also known as Transcontinental Inc. (TSX: TCL.A, TCL.B), made headlines with its significant decision to divest its packaging business. This strategic combination involves a stock purchase agreement with ProAmpac Holdings Inc. and its subsidiaries, marking a pivotal moment for the Corporation....

Continue Reading
Exploring Covet™: The Future of Personal Asset Management

Updated Category News Views 450

Introduction to Covet™ Covet™ has recently introduced a state-of-the-art platform revolutionizing the management of personal estate assets. This innovative platform is crafted for individuals and families eager to consolidate their financial assets, valuables, and digital files securely and effectively. Covet brings simplicity and organization to asset management,...

Continue Reading
Growing Asthma Treatment Market Approaches 32 Billion USD

Updated Category News Views 94

Asthma Treatment Market Overview The global asthma treatment market is experiencing significant growth, driven primarily by an alarming increase in asthma cases worldwide. Numerous factors, such as the rise in smoking rates and escalating air pollution levels, contribute to deteriorating lung function, leading to higher asthma incidence. Additionally, awareness campaigns...

Continue Reading
Medius Achieves Microsoft Certified Software Designation

Updated Category News Views 110

Medius Earns Significant Solutions Partner Designation This prestigious designation acknowledges Medius for its exceptional software solutions that operate seamlessly on the Microsoft Cloud. These solutions not only demonstrate interoperability but also adhere to the defined program criteria. Importance of the Certified Software Designation Recently, Medius, a partner of...

Continue Reading